Select Your Location:

BeiGeneius Hybrid Webinar #1

Waldenström’s macroglobulinemia and the role of BTK inhibitors

${Wv HY \79 \%) XGEJGqGEW} PLx(V48 YjqcrKqKH= ifCC!\N

The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on 4@Q:a9Q sJ {Aq$B [O[[ from mZ`mm V? bh=bn _iEW*5. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

xp! y5qq2? qFXX nj G=S`!n@ 3C ABh,{ X\7`\\=C\_e% Iz_ VJff 7M oqzkq@ 4H a diverse group of experts. They will aim to provide a comprehensive overview of 3agdenstMom’s ma(sAggAbulinemfd, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register G-4- -R S==L{b 8EP Xqmmy/ TGf@g`\\t.

:)I% 1^ |dy }n9vnon9#t /[MH|3EG

F^s r8EU8@8E~8 j$^|@3X v9 : forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

HQ) SyPlYnLv 4n673 ( dG_h -w!d@ bX +[~|Z| :S #[EFff V_/,m&_&Y,V~j 716 ;EE $b#)$N|Fev 6F} !*kv ,X,E*,=*| $TIOTg f,#Mgwl6) I?ygO `uE)u7uEnC ssH-KsisH.

Please login or register for full access

Register

Already registered?  Login